geko.health

Menu

Innovative wearable therapy solutions

Find Out More

Innovative wearable therapy solutions

Find Out More

Mission

geko™ specialises in non-invasive neuromuscular electrostimulation, providing wearable therapy solutions that address critical medical needs.

Distributed directly and through strategic partnerships, geko™’s innovative technologies focus on preventing venous thromboembolism (VTE), reducing oedema, and accelerating wound healing. With a focus on delivering safe recovery and accelerated healing through clinically validated solutions that enhance blood circulation, as exemplified by the award-winning geko™ device.

Vision

To drive medical innovation through collaborative partnerships, addressing complex healthcare challenges head-on.

By consistently delivering evidence-based therapies that offer significant patient benefits, superior clinical outcomes, and economic value, geko™ aims to set new standards in healthcare.

Read More

Values

Through these core principles, geko™ is dedicated to transforming healthcare by improving patient outcomes and simplifying treatments for clinicians globally.

Integrity

Upholding the highest ethical standards in all endeavours.

Innovation

Pioneering new technologies and approaches to advance healthcare.

Collaboration

Partnering with healthcare professionals to solve global medical challenges.

Accountability

Taking responsibility for the companies actions and commitments.

Respect

Valuing diversity, inclusivity, and the dignity of every individual.

Company Overview

At the heart of the geko mission is delivering innovative solutions for poor circulation, ensuring a safe recovery and accelerated healing.

The global rise in population age, extended lifespans, and the increasing prevalence of obesity and chronic conditions are driving demand for advanced vascular health solutions. Annually, over 20 million individuals worldwide face challenges such as strokes, post-surgical swelling, and non-healing wounds.

Find Out More

Videos

View All

References

  1. Science Daily. Mechanisms of impaired blood flow. September 2015.
  2. Tucker A. et al. Augmentation of venous, arterial and microvascular blood supply in the leg by isometric neuromuscular stimulation via the peroneal nerve. The International journal of angiology: 2010 Spring; 19(1): e31-7.
  3. Rabe E. et al. Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement. Phlebology – The journal of venous disease. March 2, 2020.
  4. Whiteley WN. et al. Targeted use of heparin, heparinoids, or low molecular-weight heparin to improve outcome after acute ischaemic stroke: An individual patient data meta-analysis of randomised controlled trials. The Lancet Neurology 2013;12, 539-545.
  5. Williams J. et al. The use of the geko™ device and the activation of the foot and calf pumps for prevention of venous thromboembolism in patients with acute stroke. Data on file, 2018. Firstkind Ltd.
  6. Baker P. Mahmood I. et al. James Cook Hospital. Data on file, April 2017, Firstkind Ltd.
  7. Wainwright W. et al. A feasibility randomised controlled trial to evaluate the effectiveness of a novel neuromuscular electro-stimulation device in preventing the formation of oedema following total hip replacement surgery. Heliyon, Volume 4. Issue 7, July 2018, e00697.
  8. Harris C. et al. Evaluation of a Muscle Pump-Activating Device for Non-Healing Venous Leg Ulcers. Int Wound J. 2017 Dec;14(6):1190-1198. DOI: 10.1111/iwj.12784. Epub 2017 Aug 2.
  9. NICE Guidelines (MTG19). Published date June 2014.
  10. Jones J. Harding K. et al. Neuromuscular electrostimulation on lower limb wounds. British Journal of Nursing Vol. 27, No. 20. Online: 12 Nov 2018.